InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: sjacobs26 post# 37854

Tuesday, 02/26/2019 3:00:48 PM

Tuesday, February 26, 2019 3:00:48 PM

Post# of 232916
Yes, you are correct, a $3B BO would be hard for BP to "stomach", but I think it could happen, if the front end offering was handled properly. I am also ambivalent about a sale now for the same reason as yourself. RP influence, leadership, and the potential for Leronlimab to treat cancer have changed the "calculus" and licensing/partnership arrangements appear to be close.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News